View in EDS PDF Full Text

Lack of pharmacokinetic drug-drug interaction between ramucirumab and irinotecan in patients with advanced solid tumors.

Saved in:
Bibliographic Details
Title: Lack of pharmacokinetic drug-drug interaction between ramucirumab and irinotecan in patients with advanced solid tumors.
Authors: Wang D; Henry Ford Hospital, 2799 West Grand Boulevard, Detroit, MI, 48202, USA. dwang1@hfhs.org., Braiteh F; Comprehensive Cancer Centers of Nevada, Las Vegas, NV, USA., Lee JJ; University of Pittsburgh School of Medicine, Pittsburgh, PA, USA., Denlinger CS; Fox Chase Cancer Center, Philadelphia, PA, USA., Shepard DR; Cleveland Clinic, Cleveland, OH, USA., Chaudhary A; Eli Lilly and Company, Indianapolis, IN, USA., Lin Y; Eli Lilly and Company, Indianapolis, IN, USA., Gao L; Eli Lilly and Company, Bridgewater, NJ, USA., Asakiewicz C; Eli Lilly and Company, Bridgewater, NJ, USA., Nasroulah F; Eli Lilly and Company, Bridgewater, NJ, USA., LoRusso P; Yale Cancer Center, New Haven, CT, USA.
Source: Cancer chemotherapy and pharmacology [Cancer Chemother Pharmacol] 2016 Oct; Vol. 78 (4), pp. 727-33. Date of Electronic Publication: 2016 Aug 09.
Publication Type: Journal Article
Journal Info: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 7806519 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0843 (Electronic) Linking ISSN: 03445704 NLM ISO Abbreviation: Cancer Chemother Pharmacol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 27507037
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Lack of pharmacokinetic drug-drug interaction between ramucirumab and irinotecan in patients with advanced solid tumors.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Wang+D%22">Wang D</searchLink>; Henry Ford Hospital, 2799 West Grand Boulevard, Detroit, MI, 48202, USA. dwang1@hfhs.org.<br /><searchLink fieldCode="AU" term="%22Braiteh+F%22">Braiteh F</searchLink>; Comprehensive Cancer Centers of Nevada, Las Vegas, NV, USA.<br /><searchLink fieldCode="AU" term="%22Lee+JJ%22">Lee JJ</searchLink>; University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.<br /><searchLink fieldCode="AU" term="%22Denlinger+CS%22">Denlinger CS</searchLink>; Fox Chase Cancer Center, Philadelphia, PA, USA.<br /><searchLink fieldCode="AU" term="%22Shepard+DR%22">Shepard DR</searchLink>; Cleveland Clinic, Cleveland, OH, USA.<br /><searchLink fieldCode="AU" term="%22Chaudhary+A%22">Chaudhary A</searchLink>; Eli Lilly and Company, Indianapolis, IN, USA.<br /><searchLink fieldCode="AU" term="%22Lin+Y%22">Lin Y</searchLink>; Eli Lilly and Company, Indianapolis, IN, USA.<br /><searchLink fieldCode="AU" term="%22Gao+L%22">Gao L</searchLink>; Eli Lilly and Company, Bridgewater, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Asakiewicz+C%22">Asakiewicz C</searchLink>; Eli Lilly and Company, Bridgewater, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Nasroulah+F%22">Nasroulah F</searchLink>; Eli Lilly and Company, Bridgewater, NJ, USA.<br /><searchLink fieldCode="AU" term="%22LoRusso+P%22">LoRusso P</searchLink>; Yale Cancer Center, New Haven, CT, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%227806519%22">Cancer chemotherapy and pharmacology</searchLink> [Cancer Chemother Pharmacol] 2016 Oct; Vol. 78 (4), pp. 727-33. <i>Date of Electronic Publication: </i>2016 Aug 09.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer+Verlag%22">Springer Verlag </searchLink><i>Country of Publication: </i>Germany <i>NLM ID: </i>7806519 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1432-0843 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2203445704%22">03445704 </searchLink><i>NLM ISO Abbreviation: </i>Cancer Chemother Pharmacol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=27507037
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s00280-016-3125-4
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 727
    Titles:
      – TitleFull: Lack of pharmacokinetic drug-drug interaction between ramucirumab and irinotecan in patients with advanced solid tumors.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Wang D
      – PersonEntity:
          Name:
            NameFull: Braiteh F
      – PersonEntity:
          Name:
            NameFull: Lee JJ
      – PersonEntity:
          Name:
            NameFull: Denlinger CS
      – PersonEntity:
          Name:
            NameFull: Shepard DR
      – PersonEntity:
          Name:
            NameFull: Chaudhary A
      – PersonEntity:
          Name:
            NameFull: Lin Y
      – PersonEntity:
          Name:
            NameFull: Gao L
      – PersonEntity:
          Name:
            NameFull: Asakiewicz C
      – PersonEntity:
          Name:
            NameFull: Nasroulah F
      – PersonEntity:
          Name:
            NameFull: LoRusso P
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 10
              Text: 2016 Oct
              Type: published
              Y: 2016
          Identifiers:
            – Type: issn-electronic
              Value: 1432-0843
          Numbering:
            – Type: volume
              Value: 78
            – Type: issue
              Value: 4
          Titles:
            – TitleFull: Cancer chemotherapy and pharmacology
              Type: main
ResultId 1